The global hypoglycemia market is anticipated to demonstrate a consistent increase in revenue throughout the projected period. The primary driver behind this revenue growth is the rising prevalence of both type 1 and type 2 diabetes. In 2021, there was a recorded total of 537 million cases of diabetes mellitus worldwide.

https://www.reportsanddata.com..../report-detail/hypog